Wireless ureteral stent sleeve enables early detection of hydronephrosis

Ureteral stents are widely used to relieve obstruction and protect kidney function, but they can also become blocked, triggering hydronephrosis and prolonged elevation of intrarenal pressure that may impair renal function. Today, clinicians mainly rely on X-rays, CT, ultrasound, or other imaging methods to identify the problem, yet these approaches are intermittent and not suited for continuous remote follow-up. Earlier smart-stent concepts showed promise, but they required direct modification of existing stent structures, complicating manufacturing and limiting flexibility. Based on these challenges, deeper research is needed into direct, continuous, noninvasive monitoring of kidney pressure in stented patients.

In a 2026 study published (DOI: 10.1038/s41378-026-01224-1) in Microsystems & Nanoengineering, a University of British Columbia-led team reported a wireless ureteral stent sleeve for early detection of hydronephrosis. The researchers developed UroSleeve to fit over standard double-J ureteral stents without altering their established design or manufacturing process. The platform combines a flexible spiral antenna with a microfabricated capacitive pressure sensor, enabling kidney pressure to be tracked through near-field inductive coupling in a biologically relevant ex vivo model.

What makes UroSleeve compelling is its blend of engineering practicality and clinical intent. The device uses a flexible printed-circuit-board spiral antenna and a Tesla-valve-enabled touch-mode capacitive pressure sensor, assembled into a passive LC tank circuit that needs no onboard battery. The sensor was designed to generate stronger capacitive signals than conventional normal-mode capacitive sensors, while the modular sleeve format preserved the native mechanics of the stent itself. To test the concept, the team inserted a stent carrying UroSleeve into an ex vivo swine kidney and ureter, then simulated hydronephrosis by raising renal pelvis pressure with fluid while reading the device wirelessly from an external antenna. The system tracked pressure increases through downward shifts in resonant frequency. Baseline phase-dip frequency was 15.234 MHz at 8.5 mmHg, and sensitivity reached −5.3 ± 0.74 kHz/mmHg over a range up to 56 mmHg. The trend was strongly pressure-driven, and post-test inspection showed visible hydroureter and renal capsule distension, confirming the presence of hydronephrotic changes. Next steps include in vivo studies to validate performance under physiological conditions.

The researchers suggest that the most important advance is not only the sensor's ability to detect pressure, but the path it offers toward translation. Because UroSleeve functions as a modular add-on rather than a fully reengineered stent, it could be adapted to multiple commercial stent platforms while easing manufacturing, optimization, and future regulatory adoption. Accordingly, the study presents the sleeve not just as a proof of concept, but as a practical framework for smarter urological monitoring that could reshape how clinicians manage one of the most serious hidden complications of ureteral stents. A wireless pressure-sensing sleeve could help detect obstruction earlier, guide the timing of stent exchange, reduce dependence on episodic radiographic imaging, and support more personalized follow-up after stones, strictures, or surgery. The paper also points toward broader clinical integration, including long-term reliability studies, biocompatibility testing, improved readout strategies, and calibration for real-world use. Ultimately, the technology aims to improve patient safety while lowering healthcare burdens linked to delayed detection of hydronephrosis.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New algorithm enables precise subtyping of metabolic liver disease